abstract |
This invention provides fully human monoclonal antibodies that recognize IL-17F, the homodimer of IL-L1F, IL-17A, the homodimer of IL-l7A, and / or the heterodimeric IL-17A / IL-17F protein complex. The invention additionally provides methods for using monoclonal antibodies as a therapeutic, diagnostic and prophylactic therapy. |